US pharma giant Pfizer has said it will sell some of its patented medicines at non-profit prices to The post Pfizer makes non-profit pledge for low-income...
NEW YORK, May 24, 2022 — Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, today announced...
With increasing concerns about COVID-19 reinfection, Pfizer and the National Institutes of Health are discussing potential studies regarding a longer treatment...
The Institute for Clinical and Economic Review recommended two out of three outpatient treatments for COVID-19 in the market today, singling out molnupiravir...
Orders for Merck & Co’s oral antiviral for COVID-19 helped to swell the drugmaker’s first quarter revenues by The post Merck makes $3.2bn from...
Britain wishes to protect its citizens by increasing access to the Pfizer Inc (NYSE: PFE) oral antiviral COVID-19 treatment. Its move will benefit thousands,...
With the rapid onset of the pandemic, the race to develop a viable vaccine quickly became a race The post Vaccine equity: how the pandemic demonstrated...
GlaxoSmithKline and Vir’s Xevudy has become the latest COVID-19 antibody therapy to have its use restricted by the The post FDA restricts GSK’s Xevudy...
UK biotech Synairgen saw the value of its shares crater after its inhaled interferon beta therapy SNG001 was The post Synairgen slumps as inhaled COVID...
Early in the COVID-19 pandemic, there was a lot of talk about the “new normal,” with most people wanting to get back to the “old normal.”...
A patent dispute between ViiV Healthcare and Gilead Sciences has been resolved, with Gilead agreeing to pay a The post ViiV claims $1.25bn settlement from Gilead...
Pfizer has called time on its alliance with Ionis for cholesterol-lowering therapy vupanorsen, after a review of phase The post Pfizer sees no way forward for...
The FDA has limited the use of COVID-19 antibody therapies developed by Eli Lilly and Regeneron, on the The post FDA bans use of Lilly, Regeneron...
The FDA has extended the emergency use authorisation for Gilead Sciences’ antiviral Veklury to include non-hospitalised patients with The post FDA clears Gilead’s Veklury for COVID...
Pfizer released data from several studies showing that nirmatrelvir, the active main protease inhibitor of the company's antiviral combination therapy Paxlovid (nirmatrelvir/ritonavir), is effective against the...
In a bid to expedite patient enrollments and to ensure diversified patient populations to support future global regulatory submissions for Bucillamine—the company’s COVID therapeutic agent currently...
The year 2020 ended on a note of hope, with the 8th December vaccination of 91-year-old Margaret Keenan, The post Nine for 2022: International issues that...
Researchers at Emory investigated the use of an FDA-approved ADHD medication on patients with mild Alzheimer’s symptoms and found it appeared to reduce levels of tau.
COVID Antiviral Pills Cause Life-Threatening Reactions With Many Common Meds Last week, the FDA authorized two much-hyped antiviral treatments for COVID (just in time for Christmas):...
Pfizer’s Paxlovid has become the first oral antiviral for COVID-19 to be authorised for emergency use by the The post Update: Pfizer pips Merck to first...
Pfizer’s Paxlovid has become the first oral antiviral for COVID-19 to be authorised for emergency use by the The post Pfizer pips Merck to first oral...
The EMA’s human medicines committee has said that EU member states can start to offer Pfizer’s oral antiviral The post As Omicron cases rise, EMA backs...
We are finally starting to get hard data on the Omicron variant of Covid-19 from its epicenter in Gauteng, South Africa. And that data, along with...
The World Health Organization updated its guidelines for COVID-19 treatments against the use of convalescent plasma for all cases of infection.
Telehealth, diagnostics and pharmacy business Truepill will launch a new virtual care platform in the coming weeks that The post Truepill preps launch of virtual COVID-19...
Merck & Co has reported new data with its oral antiviral molnupiravir that suggests it is not as The post Fall in efficacy of Merck’s molnupiravir...
We are increasingly seeing signs that the pandemic is hardly over. The European Union is battling record case levels. Areas of the US are starting to see...
Already making big profits from its COVID-19 vaccine, Pfizer looks set to bolt on another big revenue stream The post Pfizer gets bumper $5.3bn order from...
Armed with impressive new data for its oral antiviral Paxlovid, Pfizer has filed for emergency use authorisation as The post Pfizer files oral COVID pill in...
The US federal government has ordered another 1.4 million doses of Merck & Co and Ridgeback Biotherapeutics’ oral The post US buys another $1 billion-worth of...